The future of breast cancer screening and risk-reducing strategies is being shaped by artificial intelligence (AI), according to a review article published on December 12 in the journal Trends in ...

The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) has reached its enrollment goal of 108,508 women, as announced ...

Less-frequent mammographic surveillance showed a similar recurrence-free interval. Evidence Rating Level: 1 (Excellent) Study ...